ACUR panel voted 19-1 against approval. This does not bode well for their total pipeline since Niacin, which was the no way José component afas the panel was concerned, is rather prevalent as a productcomponent in their pipeline...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.